Literature DB >> 18315562

Extracellular amino acids and lipid peroxidation products in periventricular white matter during and after cerebral ischemia in preterm fetal sheep.

Mhoyra Fraser1, Laura Bennet, Pierre L Van Zijl, Tessa J Mocatta, Christopher E Williams, Peter D Gluckman, Christine C Winterbourn, Alistair J Gunn.   

Abstract

It is widely hypothesized that accumulation of excitatory amino acids, and oxygen free radicals during or after exposure to hypoxia-ischemia play a pivotal role in preterm periventricular white matter injury; however, there is limited evidence in the intact brain. In preterm fetal sheep (0.65 gestation; term 147 days) we found no significant increase in extracellular levels of excitatory amino acids measured by microdialysis in the periventricular white matter during cerebral ischemia induced by bilateral carotid occlusion. There was no significant change in 8-isoprostane or malondialdehyde levels in the early phase of recovery after occlusion. In contrast, there was a significant delayed increase in most amino acids and in malondialdehyde (but not 8-isoprostane) that was maximal approximately 2-3 days after occlusion. The increase in glutamate was significantly correlated with a secondary increase in cortical impedance, an index of cytotoxic edema, and with white matter damage 3 days post-insult. In conclusion, no significant accumulation of cytotoxins was found within immature white matter during cerebral ischemia. Although a minority of fetuses showed a delayed increase in some cytotoxins, this occurred many days after ischemia, in association with secondary cytotoxic edema, strongly suggesting that these changes are mainly a consequence of evolving cell death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18315562     DOI: 10.1111/j.1471-4159.2008.05313.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

2.  Detection of malondialdehyde in vivo using microdialysis sampling with CE-fluorescence.

Authors:  Justin Carl Cooley; Craig Edward Lunte
Journal:  Electrophoresis       Date:  2011-11       Impact factor: 3.535

Review 3.  The instrumented fetal sheep as a model of cerebral white matter injury in the premature infant.

Authors:  Stephen A Back; Art Riddle; Justin Dean; A Roger Hohimer
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  Prenatal cerebral ischemia triggers dysmaturation of caudate projection neurons.

Authors:  Evelyn McClendon; Kevin Chen; Xi Gong; Elica Sharifnia; Matthew Hagen; Victor Cai; Daniel C Shaver; Art Riddle; Justin M Dean; Alistair J Gunn; Claudia Mohr; Joshua S Kaplan; David J Rossi; Christopher D Kroenke; A Roger Hohimer; Stephen A Back
Journal:  Ann Neurol       Date:  2014-03-13       Impact factor: 10.422

Review 5.  Hypoxic-ischemic encephalopathy in the term infant.

Authors:  Ali Fatemi; Mary Ann Wilson; Michael V Johnston
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

Review 6.  The challenge of understanding cerebral white matter injury in the premature infant.

Authors:  C M Elitt; P A Rosenberg
Journal:  Neuroscience       Date:  2014-05-15       Impact factor: 3.590

7.  Modeling the encephalopathy of prematurity in animals: the important role of translational research.

Authors:  Hannah C Kinney; Joseph J Volpe
Journal:  Neurol Res Int       Date:  2012-05-23

Review 8.  The mechanisms and treatment of asphyxial encephalopathy.

Authors:  Guido Wassink; Eleanor R Gunn; Paul P Drury; Laura Bennet; Alistair J Gunn
Journal:  Front Neurosci       Date:  2014-02-27       Impact factor: 4.677

9.  The Beneficial Effects of Melatonin Administration Following Hypoxia-Ischemia in Preterm Fetal Sheep.

Authors:  Tamara Yawno; Mawin Mahen; Jingang Li; Michael C Fahey; Graham Jenkin; Suzanne L Miller
Journal:  Front Cell Neurosci       Date:  2017-09-22       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.